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ABSTRACT
Objective To evaluate the role of transvaginal power
Doppler sonography to discriminate between benign
and malignant endometrial conditions in women pre-
senting with postmenopausal bleeding and thickened
endometrium at baseline sonography.
Methods Ninety-one postmenopausal women (median
age, 58 years; range, 47–83 years) presenting with uterine
bleeding and a thickened endometrium (≥ 5-mm double-
layer endometrial thickness) on transvaginal sonography
were included in this prospective study. Endometrial
blood flow distribution was assessed in all patients by
power Doppler immediately after B-mode transvaginal
sonography. Three different vascular patterns were
defined: Pattern A: multiple-vessel pattern, Pattern B:
single-vessel pattern and Pattern C: scattered-vessel
pattern. Histological diagnoses were obtained in all cases.
No patient taking tamoxifen citrate or receiving hormone
replacement therapy was included.
Results Histological diagnoses were as follows: endome-
trial cancer: 33 (36%), endometrial polyp: 37 (41%),
endometrial hyperplasia: 14 (15%), endometrial cystic
atrophy: 7 (8%). Blood flow was found in 97%, 92%,
79% and 85% of cases of carcinoma, polyp, hyperplasia
and endometrial cystic atrophy, respectively. A total of
81.3% of vascularized endometrial cancers showed Pat-
tern A, 97.1% of vascularized polyps exhibited Pattern B
and 72.7% of vascularized hyperplasias showed Pattern
C. Sensitivity and specificity for endometrial cancer were
78.8% and 100%. For endometrial polyp these respective
values were 89.2% and 87% and for hyperplasia they
were 57.1% and 88.3%.
Conclusions Transvaginal power Doppler blood flow
mapping is useful to differentiate benign from malignant
endometrial pathology in women presenting with post-
menopausal bleeding and thickened endometrium at base-
line sonography. Copyright 2003 ISUOG. Published by
John Wiley & Sons, Ltd.
INTRODUCTION
Transvaginal sonography has been shown to be an
accurate means to rule out endometrial cancer in women
presenting with postmenopausal bleeding. A recent meta-
analysis demonstrated that the risk of endometrial cancer
when double-layer endometrial thickness as measured
by transvaginal sonography is < 5 mm is actually low1.
However, endometrial thickening is a non-specific finding
that may be caused by several processes, such as cancer,
polyps, hyperplasia or even endometrial cystic atrophy2.
Transvaginal color Doppler enables an in-vivo assess-
ment of uterine and endometrial vascularization2. The
role of this technique in differentiating benign from
malignant endometrial pathologies has been assessed
in several studies with controversial results2–7. More
recently, power Doppler or color Doppler energy has been
introduced in clinical practice. This technique offers some
advantages over conventional color Doppler sonography
that makes it a better technique for depicting vascular
networks8.
In the present study we aimed to assess the role of
transvaginal power Doppler flow mapping to discriminate
between benign and malignant endometrial conditions in
women presenting with uterine bleeding and a thickened
endometrium at baseline B-mode sonography. Further-
more, we assessed whether endometrial carcinoma, polyp
and hyperplasia exhibited different ‘typical’ vascular
patterns.
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MATERIALS AND METHODS
Ninety-one patients presenting between January 2000 and
June 2002 with postmenopausal bleeding were included
in this prospective study.
Inclusion criteria were as follows: (1) natural meno-
pause was established, defining menopause as 1 year of
absence of menstruation in women older than 45 years;
(2) baseline transvaginal sonography showing a double-
layer endometrial thickness ≥ 5 mm; (3) not taking
tamoxifen citrate or any kind of hormone replacement
therapy; (4) definitive endometrial histological diagnosis
obtained at our center. The patients’ median age was
58 years, ranging from 47 to 83 years.
Transvaginal sonography was performed in all patients
using a Toshiba SSA-370 A machine (Toshiba Medical
Systems, Tokyo, Japan) with a 5–7.5-MHz endovaginal
probe and equipped with 5-MHz color, power and
pulsed Doppler capabilities. First, conventional gray-scale
sonography was performed to obtain longitudinal and
transverse sections of the uterus. Maximum endometrial
thickness (double-layer) was measured in the longitudinal
plane. As stated above, only patients with endometrial
thickness ≥ 5 mm were included.
Thereafter, the power Doppler gate was activated
for blood flow mapping of the myometrium and
endometrium. Power Doppler settings were set to achieve
maximum sensitivity for detecting low-velocity flow
without noise (frequency, 5 MHz; power Doppler gain,
20 (range, 1–30); dynamic range, 20–40 dB; edge, 1;
persistence, 2; color map, 1; gate, 2; filter, 3).
Once the vessels had been identified the pulsed Doppler
sample volume was activated to obtain a flow velocity
waveform (FVW). Resistance index (RI), pulsatility
index (PI) and peak systolic velocity (PSV, cm/s) were
automatically calculated from three consecutive FVWs.
Conventional color Doppler was not used. In those cases
with more than one vessel identified, the lowest RI and
PI and the highest PSV found were used for analysis.
Pulsed Doppler evaluated only vessels detected within the
endometrium.
According to power Doppler flow mapping three
different vascular patterns were defined:
1. Multiple-vessel pattern (Pattern A): In this pattern mul-
tiple vessels were found within the endometrium and in
the myometrial–endometrial interface (Figure 1). This
pattern was considered as characteristic of endome-
trial cancer as it has been demonstrated that important
neoangiogenic phenomena occur in endometrial cancer
within tumor tissue and the surrounding area9.
2. Single-vessel pattern (Pattern B): In this pattern a
single prevalent vessel was identified penetrating the
endometrium from the myometrium (Figure 2). This
pattern was considered as characteristic of endometrial
polyp as this vessel is thought to correspond to the
vascularized polyp’s pedicle.
3. Scattered-vessel pattern (Pattern C): In this pattern
scanty vessels were identified scattered within the
endometrium (Figure 3). This pattern was considered
Figure 1 Power Doppler ultrasound image showing a multiple-
vessel pattern characteristic of endometrial cancer.
Figure 2 Power Doppler ultrasound image showing a single-vessel
pattern characteristic of endometrial polyp.
Figure 3 Power Doppler ultrasound image showing a scattered-
vessel pattern characteristic of endometrial hyperplasia.
as characteristic of endometrial hyperplasia since some
studies have shown that angiogenesis is limited in this
pathology9.
These patterns were defined prior to the start of the
study. The same experienced operator (J.L.A.) performed
all sonographic examinations. The examiner stated the
vascular pattern at the time of sonographic examination.
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Table 1 Power Doppler vascular patterns according to histology
Carcinoma (n (%)) Polyp (n (%)) Hyperplasia (n (%)) Cystic atrophy (n (%))
Multiple-vessel pattern 26 (81.3) 0 0 0
Single-vessel pattern 2 (6.3) 33 (97.1) 3 (27.3) 2 (33.3)
Scattered-vessel pattern 4 (12.5) 1 (2.9) 8 (72.7) 4 (66.7)
Total 32 34 11 6
Table 2 Velocimetric parameters according to histology
Carcinoma Polyp Hyperplasia Cystic atrophy
RI (mean ± SD) 0.49 ± 0.18 0.55 ± 0.14 0.53 ± 0.09 0.53 ± 0.11
PI (mean ± SD) 0.91 ± 0.67 0.96 ± 0.34 0.90 ± 0.25 0.99 ± 0.37
PSV (cm/s, mean ± SD) 10.9 ± 4.7 9.4 ± 4.2 10.7 ± 2.9 8.2 ± 2.5
Not significant for all comparisons. RI, resistance index; PI, pulsatility index; PSV, peak systolic velocity.
Sonohysterography was performed in cases in which
focal lesions, i.e. polyps, were suspected. Definitive
histological diagnoses were obtained in all cases after
dilatation and curettage (n = 40) or hysteroscopic guided
biopsy (n = 51). The method of endometrial sampling
was decided by the patient’s clinician. The pathologist
was unaware of the sonographic results.
All endometrial cancers were staged according to FIGO
criteria10.
The Kolmogorov–Smirnov test was used to assess
normal distribution of continuous data. Continuous data
were compared using one-way analysis of variance with
the Bonferroni post-hoc test or the Kruskal–Wallis test
according to whether or not the distribution was normal.
Categorical data were compared using the chi-square test.
Sensitivity, specificity and positive and negative pre-
dictive values (PPV and NPV) were calculated for each
vascular pattern. These calculations were performed by
cross-matching one group which included all the cases
with a given specific vascular pattern and a second group
which included the cases with all other vascular patterns
and also those cases in which no flow was detected, with
pathological findings.
A P-value ≤ 0.05 was considered as statistically
significant for all tests used. All statistical analyses were
performed using the SPSS 9.0 statistical package (SPSS
Inc, Chicago, IL, USA).
RESULTS
Histological diagnoses were as follows: Endometrial
cancer: 33 cases (36%), endometrial polyp: 37 cases
(41%), endometrial hyperplasia: 14 cases (15%) and
endometrial cystic atrophy: 7 cases (8%).
Mean endometrial thickness was significantly greater in
patients with endometrial cancer (13.8 mm; SD, 6.5 mm)
than in those with cystic atrophy (8.3 mm; SD, 2.2)
(P = 0.04), but not when compared with endometrial
polyps (11.4 mm; SD, 3.8) or endometrial hyperplasia
(11.9 mm; SD, 3.7).
Power Doppler signals were found in 97% (32/33) of
carcinomas, 92% (34/37) of endometrial polyps, 79%
(11/14) of endometrial hyperplasias and 85% (6/7) of
cases of endometrial cystic atrophy. A total of 81.3%
of vascularized endometrial cancers showed Pattern A,
97.1% of vascularized polyps exhibited Pattern B, and
72.7% of vascularized hyperplasias showed Pattern C.
However, 67% (4/6) atrophic endometria showed Pat-
tern C (Table 1). There were no false-positive cases for
Pattern A. Pattern B, characteristic of polyps, was asso-
ciated with seven false-positive cases: two carcinomas
arising from a polyp, three endometrial hyperplasias
and two cases with cystic atrophy. Pattern C, char-
acteristic of hyperplasia, had nine false-positive cases:
four carcinomas, one polyp and four cystic atrophic
endometria.
Velocimetric parameters were not statistically different
among different pathologies (Table 2 and Figure 4).
Sensitivity, specificity, PPV and NPV for different vascular
patterns are shown in Tables 3 to 5.
Cancer stages were as follows: Stage Ia, four (12.1%)
cases; Stage Ib, 18 (54.6%) cases; Stage Ic, four (12.1%)
cases; Stage IIIa, one (3%) case; Stage IIIc, three (9.1%)
cases; Stage IV, three (9.1%) cases.
Seventeen of 22 (77.3%) early-stage cancers (Ia and
Ib) showed Pattern A as compared with 9/11 (81.8%)
advanced-stage ( ≥ Ic) cancers (P = 0.83). Twenty-three
Table 3 Diagnostic performance of power Doppler pattern for
carcinomas
Histology
Carcinoma
(n)
Other
(n)
Multiple-vessel pattern 26 0
Other vascular pattern or no flow detected 7 58
Sensitivity, 78.8%; specificity, 100%; positive predictive value,
100%; negative predictive value, 89%.
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Figure 4 Individual values for resistance index (a), pulsatility
index (b) and peak systolic velocity (c) according to histology.
A considerable overlap is clearly seen.
(69.7%) tumors invaded < 50% of myometrium and 10
(30.3%) invaded ≥ 50% of myometrium. Seventy-seven
Table 4 Diagnostic performance of power Doppler pattern for
polyps
Histology
Polyp
(n)
Other
(n)
Single-vessel pattern 33 7
Other vascular pattern or no flow detected 4 47
Sensitivity, 89.2%; specificity, 87%; positive predictive value,
82.5%; negative predictive value, 92.2%.
Table 5 Diagnostic performance of power Doppler pattern for
hyperplasia
Histology
Hyperplasia
(n)
Other
(n)
Scattered-vessel pattern 8 9
Other vascular pattern or no flow detected 6 68
Sensitivity, 57.1%; specificity, 88.3%; positive predictive value,
47.1%; negative predictive value, 91.9%.
percent (17/23) of tumors infiltrating < 50% showed
Pattern A as compared with 90% (9/10) of tumors that
were deeply infiltrating (P = 0.57).
DISCUSSION
Endometrial carcinoma is currently the most fre-
quent gynecological cancer in western countries. Post-
menopausal bleeding is usually the first symptom.
Although only about 10–15% of women presenting with
postmenopausal bleeding will actually have an endome-
trial cancer, definitive diagnosis in this clinical setting is
warranted.
Transvaginal sonographic measurement of the endome-
trial thickness is a non-invasive method that has been
demonstrated to be accurate enough to exclude endome-
trial malignancy in women with postmenopausal bleeding.
Smith-Bindman et al.1 showed in their meta-analysis that,
using an endometrial thickness cut-off of ≥ 5 mm, the
false-negative rate in women with postmenopausal bleed-
ing not taking hormone replacement therapy was as low
as 4%.
However, endometrial thickening is a non-specific
finding that may be caused by a variety of conditions,
such as carcinoma, polyps, hyperplasia, endometritis or
cystic atrophy11, although some authors have argued
that endometrial echotexture may help to differentiate
carcinoma from polyps and hyperplasia12.
In patients with thickened endometrium a secondary
test, such as power Doppler, could play a role in refining
the diagnosis. For this reason we focused this study
on women presenting with postmenopausal bleeding
Copyright  2003 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2003; 21: 583–588.
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and a thickened endometrium at baseline transvaginal
sonography.
Transvaginal color Doppler imaging allows the assess-
ment of endometrial vascularization. Power Doppler or
color Doppler energy is a new technology that has
some advantages over conventional color Doppler. Power
Doppler is based on the amplitude of the Doppler signal
but not on the Doppler frequency shift. It is insonation-
angle independent, does not have aliasing and is more
sensitive to low-velocity blood flow8. All these features
make this technique advantageous for blood flow map-
ping by facilitating the detection of flow where present and
depicting more clearly and reliably the vascular architec-
ture. The advantages of the power Doppler technique have
been demonstrated in adnexal masses by our group13.
Based on the appearance of the typical vascular
networks of endometrial cancer, polyps and hyperplasia
as derived from immunohistochemical studies9, we
defined three different power Doppler vascular patterns
in an attempt to differentiate endometrial carcinoma
from endometrial polyps and hyperplasia. Although it
could be argued that blood flow within intratumoral
microvessels would not be detectable by power Doppler
with currently available ultrasound machines, a recent
study has demonstrated a high correlation between
microvessel density and power Doppler findings in breast
carcinoma14.
We did not include patients taking tamoxifen citrate
or receiving hormone replacement therapy because it
is known that these treatments increase uterine and
endometrial blood flow as compared with controls15–17. It
could be speculated that power Doppler vascular mapping
could show different vascular patterns in these groups of
patients.
Our results indicate that the use of these patterns
as depicted by power Doppler is useful to discriminate
endometrial carcinoma and endometrial polyps from
other pathological processes but it is not useful to
distinguish endometrial hyperplasia (sensitivity: 57%).
In the case of endometrial cancer, only one case did not
show endometrial vascularization (3%). This is in contrast
to previous studies using conventional color Doppler, in
which as many as 44–57% of the cancers had no color
signals6,7. This may be explained by the technical factors
previously mentioned.
In our series 81.3% of the vascularized endometrial
cancers showed the typical multiple-vessel pattern. Two
(6.2%) patients had the single-vessel pattern (typical of
polyps). These two cases were endometrial carcinoma
Stage IA G1 arising from an endometrial polyp. Four
patients (12.5%) showed the scattered-vessel pattern.
In the case of endometrial polyps, 34/37 (92%)
showed power Doppler signals and 33 (97%) of them
presented the single-vessel pattern. Other authors using
conventional color Doppler have also reported this typical
pattern18.
In the case of endometrial hyperplasia, most cases
showed a scattered-vessel pattern (72.7%). However, this
pattern was also shown in most cases of endometrial cystic
atrophy (66.7%), which makes it difficult to differentiate
between them.
Regarding velocimetric parameters, our results are in
agreement with those of previously reported studies2,5,7.
A considerable overlap of RI, PI and PSV values was
found, which limits their clinical use.
Previous studies using power Doppler for the diagnosis
of endometrial pathology are rare. Amit et al.19 used
power Doppler to identify endometrial vessels but then
used PI (cut-off PI ≤ 1.0) as a selection criterion to
discriminate between endometrial carcinoma and benign
conditions. They found that power Doppler plus PI
had higher sensitivity and specificity as compared with
measurement of endometrial thickness alone. However,
they did not analyze conventional color Doppler imaging.
Kurjak et al.20 reported on the use of three-dimensional
power Doppler sonography to diagnose endometrial can-
cer. They found that this technique had a higher sensitivity
as compared with two-dimensional conventional color
Doppler (89% vs. 67%) with identical specificity (97%
for both). However, three-dimensional equipment is still
expensive and not available in most ultrasound units.
We have not compared power Doppler with con-
ventional color Doppler because all examinations were
performed by the same operator and the use of color
Doppler before or after power Doppler could introduce a
bias when evaluating the findings of power Doppler blood
flow mapping.
Our results are in agreement with a recent report
of Epstein et al.21, who found that power Doppler
can contribute to a correct diagnosis of endometrial
malignancy in women with postmenopausal bleeding and
endometrial thickness > 5 mm. However, in contrast to
our study they used a rather more sophisticated approach
by applying logistic regression models and they focused
on the specific diagnosis of endometrial carcinoma.
A possible limitation of our study is the high prevalence
of endometrial cancer in our series (36%) (three times
higher than expected) representing a potential selection
bias. This can be explained by the fact that our sample was
a selected one (only patients with thickened endometria
were included) and because our institution is a tertiary
care university hospital specializing in gynecological
oncology. Furthermore, we did not assess reproducibility
in this study, which represents a weakness.
In conclusion, the use of power Doppler blood flow
mapping as a secondary test in women not taking hormone
replacement therapy or tamoxifen presenting with
postmenopausal bleeding and a thickened endometrium
at baseline sonography is useful to discriminate carcinoma
and polyps from other causes of endometrial thickening.
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